Bija Ventures

Bija Ventures is an early-stage venture capital firm founded in 2025 that invests in biotechnology companies before Series A. The firm backs founders building computationally enabled therapeutic platform companies - those with a technology or data edge drawn from computational biology, data-driven drug discovery, or AI/ML-enabled therapeutic development. Its approach is indication- and modality-agnostic, focused on FDA-regulated therapeutics for serious diseases.

Investments are made at the pre-Series A stage, supporting programs from development-candidate nomination through first-in-human trials. Bija operates as an active co-investor, joining strong syndicates rather than requiring a lead position. Beyond capital, the firm shares operational playbooks, fundraising guidance, and market perspectives with founders - a function informed by a team with experience as both scientists and biotech operators, and first-hand knowledge of the challenges in moving research toward patient care.

The firm is based in Aspen, Colorado, and has a geographic investment footprint spanning four countries: the United States, the United Kingdom, Canada, and Australia.